MedPath

LABORATORI GUIDOTTI SPA

🇮🇹Italy
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.labguidotti.it

Clinical Trials

1

Active:0
Completed:1

Trial Phases

0 Phases

Drug Approvals

3

NMPA:2
CIMA_AEMPS:1

Drug Approvals

Rociverine Tablets

Product Name
里拉通
Approval Number
国药准字HJ20150471
Approval Date
Mar 21, 2024
NMPA

Rociverine Tablets

Product Name
里拉通
Approval Number
H20150471
Approval Date
May 10, 2019
NMPA

Clinical Trials

Observational Study On The Characterization Of 24-Hour Symptoms In Patients With COPD

Completed
Conditions
Chronic Obstructive Pulmonary Disease
First Posted Date
2017-04-10
Last Posted Date
2018-08-22
Lead Sponsor
Laboratori Guidotti S.p.A.
Target Recruit Count
683
Registration Number
NCT03105999
Locations
🇮🇹

Ospedale Ecclesiastico Miulli - Fisiopatologia Respiratoria, Acquaviva delle Fonti, Bari, Italy

🇮🇹

A.O. Mellino Mellini - U.O. Fisiopatologia Respiratoria, Chiari, Brescia, Italy

🇮🇹

Clinica Padre Pio - Medicina, Mondragone, Caserta, Italy

and more 37 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.